A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Cited by (1,002)

Items 701–800 of 1,002

1. Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction
   Xinsong Chen, Emmanouil G. Sifakis, Stephanie Robertson, Shiyong Neo, Seong-Hwan Jun, Le Tong, Apple H.M. Tay, John Lövrot, Roxanna Hellgren, Sara Margolin et al. · 2022 · Proceedings of the National Academy of Sciences
2. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
   Xiaoxi Xu, Shuzhong Wang, Jun Zhou, Jing Chen, yujun Huang, Rajendra Kumari, Binchen Mao, Meiling Zheng, Xiaoyu An, xiaolong tu et al. · 2023 · PLoS ONE
3. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer
   Yukun Chen, Yujun Liu, Shimin Chen, Long Zhang, Jiawei Rao, Xinjun Lu, Yi Ma · 2023 · Frontiers in Immunology
4. Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma
   Fumihiro Watanabe, Ethan W. Hollingsworth, Jenna M. Bartley, Lauren Wisehart, Rahil Desai, Annalisa M. Hartlaub, Mark E. Hester, Paula V. Schiapparelli, Alfredo Quiñones‐Hinojosa, Jaime Imitola · 2024 · PNAS Nexus
5. Dynamic in vitro models for tumor tissue engineering
   Daniel Karami, Nathan R. Richbourg, Vassilios I. Sikavitsas · 2019 · Cancer Letters
6. Tracking Photodynamic- and Chemotherapy-Induced Redox-State Perturbations in 3D Culture Models of Pancreatic Cancer: A Tool for Identifying Therapy-Induced Metabolic Changes
   Mans Broekgaarden, Anne‐Laure Bulin, Jane Frederick, Zhiming Mai, Tayyaba G. Hasan · 2019 · Journal of Clinical Medicine
7. Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
   Chiara Argentati, Ilaria Tortorella, Martina Bazzucchi, Francesco Morena, Sabata Martino · 2020 · Journal of Personalized Medicine
8. Cancer Cell Invasion of Mammary Organoids with Basal‐In Phenotype
   Eric Parigoris, Soojung Lee, David R. Mertz, Madeleine C. Turner, Amy Y Liu, Jason Sentosa, Sabra I. Djomehri, Hao Chen Chang, Kathryn E. Luker, Gary D. Luker et al. · 2020 · Advanced Healthcare Materials
9. Comparison of primary and passaged tumor cell cultures and their application in personalized medicine
   Pipiya, Vladislava V., Gilazieva, Zarema E., Issa, Shaza S., Rizvanov, Albert A., Solovyeva, Valeriya V. · 2024 · Exploration of Targeted Anti-tumor Therapy
10. Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation
    Abel Soto-Gamez, Jeremy P Gunawan, Lara Barazzuol, Sarah A. Pringle, Robert Paul Coppes · 2024 · Stem Cells
11. An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche
    Ilaria Baldassarri, Daniel Naveed Tavakol, Pamela L. Graney, Alan G. Chramiec, Hanina H. Hibshoosh, Gordana Vunjak‐Novakovic · 2024 · Proceedings of the National Academy of Sciences
12. Mitochondrial-uncoupling nanomedicine for self-heating and immunometabolism regulation in cancer cells
    Zhe Yang, Ying Zhou, Xiaozhen Liu, Liujiao Ren, Xinyang Liu, Rong Yun, Liangliang Jia, Xuechun Ren, Ying Wang, Yan Sun et al. · 2024 · Biomaterials
13. Patient-Derived Organoids: A Game-Changer in Personalized Cancer Medicine
    Mohammad Hadi Abbasian, Navid Sobhani, Mahsa Mollapour Sisakht, Alberto D’Angelo, Marianna Sirico, Raheleh Roudi · 2024 · Stem Cell Reviews and Reports
14. Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights
    Xinyu Li, Haiying Zhao · 2025 · Experimental Hematology and Oncology
15. CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer
    Alina Catalina Palcau, Claudio Pulito, Valentina De Pascale, Luca Casadei, Mariacristina Valerio, Andrea Sacconi, Valeria Canu, Daniela Rutigliano, Sara Donzelli, Federica Lo Sardo et al. · 2025 · Journal of Experimental & Clinical Cancer Research
16. p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
    Dong Hu, Xiaoshuang Lyu, Zheqi Li, Prasanna Ekambaram, Anushka Dongre, Tanner J. Freeman, Marion Joy, Jennifer M. Atkinson, Daniel D. Brown, Zongyou Cai et al. · 2025 · Nature Cancer
17. A combined enteric neuron-gastric tumor organoid reveals metabolic vulnerabilities in gastric cancer
    Becky K.C. Chan, Chu Zhang, Chi Him Poon, Marie H.Y. Lee, Hoi Yee Chu, Bei Wang, Sin-Guang Chen, Helen H.N. Yan, Suet Yi Leung, Alan S.L. Wong · 2025 · Cell stem cell
18. Inhibition of lovastatin- and docosahexaenoic acid-initiated autophagy in triple negative breast cancer reverted resistance and enhanced cytotoxicity
    Nahla E. El‐Ashmawy, Ghada M. Al‐Ashmawy, Eman A Amr, Eman Gouda Khedr · 2020 · Life Sciences
19. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform
    Bo Pan, Dongyi Zhao, Yaqian Liu, Na Li, Chen Song, Ning Li, Xuelu Li, Zuowei Zhao · 2021 · In Vitro Cellular & Developmental Biology - Animal
20. Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs
    Michael P. Smith, Harriet R. Ferguson, Jennifer Ferguson, Egor Zindy, Katarzyna M. Kowalczyk, Thomas Kedward, Christian Bates, Joseph Parsons, Joanne Watson, Sarah Chandler et al. · 2021 · The EMBO Journal
21. Optimization of tumor spheroid model in mesothelioma and lung cancers and anti-cancer drug testing in H2052/484 spheroids
    Dylan AJ Gendre, Edis Ameti, Wolfram Karenovicŝ, Nadja Perriraz, Frédéric Triponez, Véronique Serre‐Beinier · 2021 · Oncotarget
22. An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers
    Bo Wang, Jiaxing Gan, Zhengyan Liu, Zhixuan Hui, Jinhui Wei, Xiaolian Gu, Yabing Mu, Guangxiang Zang · 2022 · Journal of Experimental & Clinical Cancer Research
23. Fluorescence intensity and lifetime imaging of lipofuscin-like autofluorescence for label-free predicting clinical drug response in cancer
    Yinghan Yan, Fuqiang Xing, Jiayue Cao et al. · 2022 · Redox Biology
24. Establishment and characterization of canine mammary tumoroids for translational research
    Antonella Raffo‐Romero, Soulaimane Aboulouard, Emmanuel Bouchaert, Agata Marta Rybicka, Dominique Tierny, Nawale Hajjaji, Isabelle Fournier, Michel Salzet, Marie Duhamel · 2023 · BMC Biology
25. Measuring and modelling tumour heterogeneity across scales
    Garrett F. Beeghly, Adrian A. Shimpi, Robert N. Riter, Claudia Fischbach · 2023 · Nature Reviews Bioengineering
26. Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid‐Based 3D In Vitro Models
    Natalie Landon‐Brace, Nancy T. Li, Alison P. McGuigan · 2023 · Advanced Healthcare Materials
27. Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
    Xinxin Rao, Zhibin Qiao, Yang Yang, Yun Deng, Zhen Zhang, Xiaoli Yu, Xiaomao Guo · 2024 · Pharmaceuticals
28. Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside
    Luca Varinelli, Davide Battistessa, Marcello Guagliò, Susanna Zanutto, Oscar Illescas, Ewelina Lorenc, Federica Pisati, Shigeki Kusamura M. D, Laura Cattaneo, Giovanna Sabella et al. · 2024 · Journal of Experimental & Clinical Cancer Research
29. Rat Models of Hormone Receptor-Positive Breast Cancer
    Raquel Nicotra, Catrin Lutz, Hendrik A. Messal, Jos Jonkers · 2024 · Journal of Mammary Gland Biology and Neoplasia
30. A Novel Human Colon Signet-Ring Cell Carcinoma Organoid Line: Establishment, Characterization and Application
    Yaqi Li, Renjie Wang, Dan Huang, Xiaoji Ma, Shaobo Mo, Qiang Guo, Guoxiang Fu, Yuanchuang Li, Xiaoya Xu, Xiang Hu et al. · 2019 · Carcinogenesis
31. A growth factor-reduced culture system for colorectal cancer organoids
    Ronghui Tan, Ze Zhang, Peirong Ding, Yue Liu, Huidong Liu, Minyi Lu, Ye‐Guang Chen · 2024 · Cancer Letters
32. The biological macromolecules constructed Matrigel for cultured organoids in biomedical and tissue engineering
    Ke-yu Zhao, Yu Du, Huimin Cao, Liya Su, Xiulan Su, Xian Li · 2024 · Colloids and Surfaces B Biointerfaces
33. A New Perspective on Precision Medicine: The Power of Digital Organoids
    Qian Yang, Mengmeng Li, Zian Xiao, Yekai Feng, Lanjie Lei, Shisheng Li · 2025 · Biomaterials Research
34. Human Organoids and Their Application in Tumor Models, Disease Modeling, and Tissue Engineering
    Siyuan Song, Zheng Liu, Yi Wang, Bo Gong · 2025 · Medicine Bulletin
35. Breast tumor kinase (Brk/PTK6) mediates advanced cancer phenotypes via SH2-domain dependent activation of RhoA and aryl hydrocarbon receptor (AhR) signaling
    A. Dwyer, Carlos Perez Kerkvliet, R. Krutilina, Hilaire C. Playa, D. Parke, Warner Thomas, B. Smeester, B. Moriarity, T. Seagroves, C. Lange · 2020 · Molecular Cancer Research
36. The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma
    Elizabeth R. Tucker, Sally L. George, Paola Angelini, Alejandra Bruna, Louis Chesler · 2021 · Journal of Personalized Medicine
37. New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas
    Cristina Porcheri, Thimios A. Mitsiadis · 2021 · Cancers
38. Anticancer and chemosensitization effects of cannabidiol in 2D and 3D cultures of TNBC: involvement of GADD45α, integrin-α5, -β5, -β1, and autophagy
    Sunil Kumar Surapaneni, Nilkumar Patel, Li Jun Sun, Nagavendra Kommineni, Anil Kumar Kalvala, Aragaw Gebeyehu, Peggy Arthur, Leanne C. Duke, Ramesh Nimma, David G. Meckes et al. · 2022 · Drug Delivery and Translational Research
39. Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer
    Minglu Hao, Zhipeng Cao, Zhiwei Peter Wang, Jianjun Xin, Biao Kong, Jing Xu, Lei Zhang, Pu Chen · 2022 · ACS Biomaterials Science & Engineering
40. Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma
    Ashuvinee Elangovan, Jagmohan Hooda, Laura Savariau, Susrutha Puthanmadhomnarayanan, Megan E. Yates, Jian Chen, Daniel D. Brown, Priscilla F. McAuliffe, Steffi Oesterreich, Jennifer M. Atkinson et al. · 2022 · Molecular Cancer Research
41. Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
    Carlos A. Huertas-Caro, Mayra A. Ramirez, Henry Joseth González-Torres, María Carolina Sanabria‐Salas, Silvia Juliana Serrano-Gomez · 2022 · Frontiers in Oncology
42. A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
    Sara Donzelli, Mario Cioce, Andrea Sacconi, Francesca Zanconato, Theodora Daralioti, Frauke Goeman, Giulia Orlandi, Simona Di Martino, Vito Michele Fazio, Gabriele Alessandrini et al. · 2022 · Molecular Cancer
43. Tumor Organoid Model and Its Pharmacological Applications in Tumorigenesis Prevention
    Xiaolei Cao, Wenjie Zheng, Yuwei Qiang, Ninghua Yao, Fan Zuo, Shi Qiu · 2022 · Current Molecular Pharmacology
44. Metformin and simvastatin synergistically suppress endothelin 1‐induced hypoxia and angiogenesis in multiple cancer types
    Jie Liu, Huxia Wang, Miao Zhang, Yazhao Li, Ruiqi Wang, He Chen, Bo Wang, Xiaoqian Gao, Shaoran Song, Yaochun Wang et al. · 2022 · Cancer Science
45. Will Organoids Fill the Gap towards Functional Precision Medicine?
    Federica Papaccio, Manuel Cabeza-Segura, Blanca García-Micó, Noelia Tarazona, Desamparados Roda, Josefa Castillo, Andrès M.R. Cervantes · 2022 · Journal of Personalized Medicine
46. Organoids technology for advancing the clinical translation of cancer nanomedicine
    Dong‐Kun Zhao, Jie Liang, Xiao‐Yi Huang, Song Shen, Jun Wang · 2023 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
47. The EstroGene Database Reveals Diverse Temporal, Context-Dependent, and Bidirectional Estrogen Receptor Regulomes in Breast Cancer
    Zheqi Li, Tianqin Li, Megan E. Yates et al. · 2023 · Cancer Research
48. Organoids reveal cancer dynamics
    Calvin Jay Kuo, Christina N. Curtis · 2018 · Nature
49. Brain Organoids: A Promising Living Biobank Resource for Neuroscience Research
    Shuang Li, Min Wang, Junmei Zhou · 2020 · Biopreservation and Biobanking
50. Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model
    Vince Kornél Grolmusz, Jinfeng Chen, Rena Emond, Patrick A. Cosgrove, Lance T. Pflieger, Aritro Nath, Philip J. Moos, Andrea H. Bild · 2020 · Cancer Cell International
51. Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses
    Xuefeng Liu, Yuntao Wu, Lijun Rong · 2020 · Virologica Sinica
52. Establishment and characterization of breast cancer organoids from a patient with mammary Paget’s disease
    Bo Pan, Dongyi Zhao, Yaqian Liu, Na Li, Chen Song, Ning Li, Xuelu Li, Man Li, Zuowei Zhao · 2020 · Cancer Cell International
53. Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
    Meili Zhang, J. Jeya Vandana, Lauretta A. Lacko, Shuibing Chen · 2020 · Stem Cell Research
54. Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma
    Ling Li, Gilad Halpert, Michael G. Lerner, Hai‐Jie Hu, Peter Michael Dimitrion, Matthew John Weiss, Jin Peng He, Benjamin Philosophe, Richard Andrew Burkhart, William Reece Burns et al. · 2021 · JCI Insight
55. Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib
    Muhammed M. Salahuddin, Gamal A. Omran, Maged W. Helmy · 2021 · Current Issues in Molecular Biology
56. Creating rat hepatocyte organoid as an in vitro model for drug testing
    He, Yu-Ting, Zhu, Xing-Long, Li, Sheng-Fu, Zhang, Bing-Qi, Li, Yi, Wu, Qiong, Zhang, Yun-Lin, Zhou, Yan-Yan, Li, Li, Qi, Ya-Na et al. · 2020 · World Journal of Stem Cells
57. Innovating cancer drug discovery with refined phenotypic screens
    Zhenyi Wang, Alžbeta Hulíková, Pawel Swietach · 2024 · Trends in Pharmacological Sciences
58. Microdissection tools to generate organoids for modeling the tumor immune microenvironment
    Seth C. Cordts, Kanako Yuki, Maria Fernanda Henao Echeverri, Balasubramanian Narasimhan, Calvin Jay Kuo, Sindy K. Y. Tang · 2024 · Microsystems & Nanoengineering
59. Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
    Danqing Zhu, Wonjoon Kim, Hyunjin Lee, Xiaoping Bao, Pilnam Kim · 2025 · Advanced Materials
60. Organoids technology in cancer research: from basic applications to advanced ex vivo models
    Luca Varinelli, Oscar Illescas, Ewelina Lorenc, Davide Battistessa, Marzia Di Bella, Susanna Zanutto, Manuela Gariboldi · 2025 · Frontiers in Cell and Developmental Biology
61. Prediction of CAR‐T Therapy In Vitro: Development of Biomimetic Models for CAR‐T Killing Effect Assessment
    Xuan Sun, Zilin Zhang, Wentao Zhao, Shihui Xu, Jing Zhang, Xue-Mei ZhuanSun, Jiexian Ye, Yanyan Han, Zhongze Gu, Zaozao Chen · 2025 · Small
62. From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures
    Yuen‐Yi Tseng, Jesse S. Boehm · 2019 · Current Opinion in Genetics & Development
63. Current status and perspectives of patient-derived rare cancer models
    Tadashi Kondo · 2020 · Human Cell
64. Novel organoid model in drug screening: Past, present, and future
    Xialin Nie, Zhixing Liang, Kun Li, Haoyuan Yu, Yu‐Han Huang, Linsen Ye, Yang� Yang · 2021 · Liver Research
65. Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts
    Jianyong Zhuo, Di Lu, Jianguo Wang, Zhengxing Lian, Jiali Zhang, Huihui Li, Beini Cen, Xuyong Wei, Qiang Wei, Haiyang Xie et al. · 2021 · Chinese Journal of Cancer Research
66. Patient-derived xenograft culture-transplant system for investigation of human breast cancer metastasis
    Dennis Ma, Grace A. Hernandez, Austin E.Y.T. Lefebvre, Hamad S. Alshetaiwi, Kerrigan Blake, K. Davé, Maha Rauf, Justice Williams, Ryan T. Davis, Katrina T. Evans et al. · 2021 · Communications Biology
67. Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model
    Sunil Singh, Astha Lamichhane, Pouria Rafsanjani Nejad, Jacob Heiss, Hannah Baumann, Ravindra Gudneppanavar, Nic D. Leipzig, Michael Konopka, Gary D. Luker, Hossein Tavana · 2022 · Molecular Cancer Research
68. Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics
    Elena Garré, Anna Gustafsson, Maria Carmen Leiva, Joakim Håkansson, Anders Ståhlberg, Anikó Kovács, Göran Landberg · 2022 · Cancers
69. GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
    Gaia Bianco, Mairene Coto‐Llerena, John Gallon, Venkatesh Kancherla, Stephanie Taha‐Mehlitz, Mattia Marinucci, Martina Konantz, Sumana Srivatsa, Hesam Montazeri, Federica Panebianco et al. · 2022 · Communications Biology
70. Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1– Mediated Gemcitabine Chemoresistance
    Zhiqing Bai, Zhiying Guo, Jiaxing Liu, Yu-Ann Chen, Qian Lü, Ping Zhang, Lili Hong, Yunfang Wang, Jiahong Dong · 2022 · Frontiers in Oncology
71. Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models
    Åsmund Flobak, Sigrid Strand Skånland, Eivind J. Hovig, Kjetil Taskén, Hege Giercksky Russnes · 2022 · Trends in Pharmacological Sciences
72. Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq
    Gaetana Restivo, Aizhan Tastanova, Zsolt Balázs, Federica Panebianco, Maren Diepenbruck, Caner Ercan, Bodgan-T. Preca, Jürg Hafner, William P. Weber, Christian Kurzeder et al. · 2022 · Communications Biology
73. Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis
    Jieqiong Zhang, Zhenhua Hu, Hwa Hwa Chung, Yun Tian, Kah Weng Lau, Zheng Ser, Yan Ting Lim, Radoslaw Mikolaj Sobota, Hwei Fen Leong, Benjamin Jieming Chen et al. · 2023 · Nature Communications
74. Cellular agriculture for milk bioactive production
    Lucile Yart, Andy Wiranata Wijaya, Maria João Lima, Corinne Haller, Eline M. van der Beek, Ryan S Carvalho, Marine R.-C. Kraus, Omid Mashinchian · 2023 · Nature Reviews Bioengineering
75. KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer
    Litong Yao, Qian Hao, Mozhi Wang et al. · 2023 · Oncogene
76. The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin α6 mRNA splicing
    Dimpi Mukhopadhyay, Hira Lal Goel, Choua Xiong, Shivam Goel, Ayush Kumar, Rui Li, Lihua Julie Zhu, Jennifer L. Clark, Michael A. Brehm, Arthur M. Mercurio · 2023 · Cell Reports
77. Advancements in 3D In Vitro Models for Colorectal Cancer
    Sara Vitale, Federica Calapà, Francesca Colonna, Francesca Luongo, Mauro Biffoni, Ruggero D. Maria, Micol Eleonora Fiori · 2024 · Advanced Science
78. The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care
    John G. Clohessy, Pier Paolo Pandolfi · 2018 · Frontiers in Oncology
79. Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
    Po Hien Ear, Guiying Li, Meng Wu, Ellen Abusada, Andrew M. Bellizzi, James R. Howe · 2019 · Journal of Visualized Experiments
80. Engineering Prostate Cancer from Induced Pluripotent Stem Cells—New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies
    Anastasia C. Hepburn, Clive Sims, Adriana Buskin, Rakesh Heer · 2020 · International Journal of Molecular Sciences
81. Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
    Diana Corallo, Stella Frabetti, Olivia Candini, Elisa Gregianin, Massimo Dominici, Horst Fischer, Sanja Aveic · 2020 · Frontiers in Immunology
82. Tumor organoid model of colorectal cancer (Review)
    Chi Yang, Wangwen Xiao, Rui Wang, Yan Hu, Ke Yi, Xuan Sun, Guanghui Wang, Xiaohui Xu · 2023 · Oncology Letters
83. Breast cancer organoids and their applications for precision cancer immunotherapy
    Dandan Guan, Xiaozhen Liu, Qingyang Shi, Bangjie He, Chaopeng Zheng, Xuli Meng · 2023 · World Journal of Surgical Oncology
84. Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges
    Martina Radić, Martin Egger, Marianna Kruithof‐de Julio, Roland Seiler · 2024 · European Urology Focus
85. Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications
    Colin D. Paul, Chris Yankaskas, Pradip Shahi Thakuri, Brittany N. Balhouse, Shyanne Salen, Amber Bullock, Sylvia Beam, Anthony Chatman, Sybelle Djikeng, Xiaoyu Jenny Yang et al. · 2025 · Scientific Reports
86. New developments and applications of human organoids
    Amanda Andersson-Rolf, Hans C. Clevers · 2026 · Nature Reviews Molecular Cell Biology
87. Bioengineered tumor organoids
    Anthony J. Dominijanni, Andrea R. Mazzocchi, Ethan Shelkey, Steven Donald Forsythe, Mahesh Devarasetty, Shay Söker · 2020 · Current Opinion in Biomedical Engineering
88. Drug Repurposing in Oncology: Current Evidence and Future Direction
    Zhenzhan Zhang, Jianguang Ji, Hao Liu · 2020 · Current Medicinal Chemistry
89. 3D Modeling of Epithelial Tumors—The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology
    Poonam Trivedi, Rui Liu, Hongjie Bi, Chunlin Xu, Jessica M. Rosenholm, Malin Åkerfelt · 2021 · International Journal of Molecular Sciences
90. Multimodal predictors for precision immunotherapy
    Lisanne M. Roelofsen, Paulien Kaptein, Daniela S. Thommen · 2022 · Immuno-Oncology Technology
91. Preclinical Models of Brain Metastases in Breast Cancer
    Natasha N. Knier, Sierra Pellizzari, Jiangbing Zhou, Paula J. Foster, Armen E. Parsyan · 2022 · Biomedicines
92. In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
    Gary J. Cheng, Euphemia Yee Leung, Dean C. Singleton · 2022 · Exploration of Targeted Anti-tumor Therapy
93. Glucocorticoids enhance chemotherapy-driven stress granule assembly and impair granule dynamics, leading to cell death
    Avital Schwed-Gross, Hila Hamiel, Gabriel P. Faber, Mor Angel, Rakefet Ben-Yishay, Jennifer I. C. Benichou, Dana Ishay-Ronen, Yaron Shav‐Tal · 2022 · Journal of Cell Science
94. Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins
    Jenna E. van Leeuwen, Wail Ba-Alawi, Emily Branchard, Jennifer Cruickshank, Wiebke Schormann, Joseph Longo, Jennifer Silvester, Peter L. Gross, David William Andrews, David W. Cescon et al. · 2022 · Nature Communications
95. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms
    Božena Smolková, Agapi Kataki, Julie Earl, Ignacio Ruz‐Caracuel, Marina Cihova, Maria Urbanova, Verona Buociková, Sandra Tamargo, Vita Rovīte, Helvijs Niedra et al. · 2022 · Critical Reviews in Oncology/Hematology
96. Clinical applications of 3D normal and breast cancer organoids: A review of concepts and methods
    Steven M. Lewis, Mackenzie K. Callaway, Camila O. dos Santos · 2022 · Experimental Biology and Medicine
97. The tumor microenvironment and immune targeting therapy in pediatric renal tumors
    Amy B Hont, Benoît Dumont, Kathryn S. Sutton, John Anderson, Alex Kentsis, Jarno Drost, Andrew Lee Hong, Arnauld C. Verschuur · 2022 · Pediatric Blood & Cancer
98. Organoid Culture Development for Skeletal Systems
    Jia Qing, Qian Guo, Longwei Lv, Xiao Zhang, Yunsong Liu, Boon Chin Heng, Zheng Li, Ping Zhang, Yongsheng Zhou · 2023 · Tissue Engineering Part B Reviews
99. Natural products as drug candidates for breast cancer (Review)
    NITIN T. TELANG · 2023 · Oncology Letters
100. A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids
     Ruixin Yang, Yutong Du, Wingyan Kwan, Ranlin Yan, Qimeng Shi, Lu Zang, Zhenggang Zhu, Jianming Zhang, Chen Li, Yingyan Yu · 2023 · Cancer Biology and Medicine